ArticlePlant biotechnology journal2026
Overexpression of a Tonoplast Malate Transporter Gene Leads to Enhanced Anthocyanin Biosynthesis in Apple.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MdMYB41L mediates stamen development and anthocyanin biosynthesis in apple.Frontiers in plant science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Anthocyanins, a group of secondary metabolites synthesised in the phenylpropanoid pathway, largely determine the peel colour of fleshy fruits, but it is not known if their synthesis is linked to vacuolar malate accumulation that underlies fruit acidity. Here, we show that when the coding sequence of Ma1 (cMa1), encoding a tonoplast malate transporter for controlling apple fruit acidity, is overexpressed in 'Royal Gala' apple, anthocyanin biosynthesis in the fruit peel is enhanced, corresponding to the downregulation of the expression of MdMYB73, a transcriptional activator for Ma1. RNAi suppression of MdMYB73 expression increases anthocyanin biosynthesis whereas its transient overexpression decreases anthocyanin biosynthesis in apple fruit peel. MdMYB73 binds to all 7 MYB-sites in the promoter of the gene encoding UDP-glucose: flavonoid-3-O-glucosyltransferase (UFGT), the enzyme that catalyses the last step in anthocyanin synthesis, to repress its expression. When MdMYB73 expression is suppressed by RNAi, MdUFGT expression is enhanced, leading to more anthocyanin synthesis, but this effect is blocked by RNAi suppression of MdUFGT expression. In addition, MdMYB73 competes with MdMYB1, a key transcriptional activator of anthocyanin synthesis, by binding to the same MYB-sites in the promoter of MdUFGT. These results indicate that, in addition to being a transcriptional activator for Ma1, MdMYB73 negatively regulates anthocyanin biosynthesis via repressing MdUFGT expression and competing with MdMYB1 for binding to the MdUFGT promoter in apple peel. In cMa1-OE fruits, downregulation of MdMYB73 releases MdUFGT from MdMYB73 repression, which allows more MdMYB1 to bind to the promoter of MdUFGT, leading to enhanced anthocyanin biosynthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.